Breast Cancer 2023 | Dubai | UAE | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

One team, One dream, Let's find a cure

- Breast Cancer 2023

Welcome Message

It is with great pleasure and excitement that we extend a warm welcome to all of you to the 12th European Congress on Breast Cancer ,Women's Health and Therapeutics. This highly anticipated event will be held in the captivating city of Dubai, UAE, from December 7th to 9th, 2023.

The theme of the conference is One team, One dream, Let’s find a cure. The conference is scheduled on Dec 07-09, 2023 at Dubai, UAE

Breast Cancer 2023 offers a venue for networking with renowned professionals from other nations and presents a chance to advance one's career. The conference schedule includes plenary sessions, poster presentations, special sessions, keynote addresses, and much more. The purpose of this conference is to bring together all of the research scholars, academic researchers, medical professionals, clinical healthcare specialists, and young researchers in order to raise the bar for academic excellence.

The scientific conference cover topics such as male Breast Cancer, Gynecology and obstetrics, new clinical trials, and Breast Cancer surgery. This conference acts as a fantastic forum for discussion and gives researchers insight into innovation, development, cures, and progression.

We sincerely welcome everyone to Breast Cancer 2023 and are delighted to offer a venue in The Netherlands with the goal is to impacting science. We are hoping that you will all attend our conference and work with us to improve women's health.

Market Analysis

Market analysis:

The global diagnostics of breast cancer 2023 market was worth USD 3.9 billion in 2020 and is predicted to increase at a compound annual growth rate (CAGR) of 7.0% between 2021 and 2028. The increased prevalence of cancer and rising government measures to influence screening and diagnosis rates can be related to the increase. The market for women’s health diagnostics is anticipated to be driven by the rising incidence of Breast cancer. According to the American Cancer Society, 281,550 new instances of breast cancer will be discovered in 2021, and 49,290 Americans will pass away from the disease. The WHO, Breast cancer will be the most frequent type of cancer in the world in 2021, with more than 2.3 million new cases.

Growing demand for technologically advanced devices that may improve accuracy, speed, and cost-effectiveness is expected to be the most important growth factor over the projection period. In the field of cancer diagnostics, for example, Direct-To-Consumer (DTC) testing has been introduced. The U.S. FDA approved 23andMe's first DTC BRCA test, which was released in 2018. It is one of the earliest direct-to-consumer tests (DTC) for BRCA gene abnormalities, which raise the risk of breast and ovarian cancer. The instrument-based testing segment lead the Breast cancer diagnostics market in 2020, accounting for 72.7% of total revenue

Europe Breast Cancer Therapeutics 2023 Market reached USD 8.2 billion and is expected to grow at a 7.1% CAGR between 2024 and 2028. Breast cancer therapeutics belongs to the therapeutic approach used in the treatment or management of local recurrence and metastatic Breast cancer spread. Breast cancer 2023 therapeutics in the form of immunotherapy, hormonal therapy, chemotherapy, targeted therapy, or a combination of these therapies are increasingly preferred in cases of metastatic relapse risk. The presence of major players, well-established diagnostic and screening infrastructure, technological advancements, high patient awareness, and healthcare expenditure are the major factors contributing to this region's dominance.

According to the World Health Organization, screening with mammography clearly reduces breast cancer 2023 mortality. In women aged 50 and up, an optimal cancer screening program with adequate compliance could reduce Breast cancer mortality by at least 20%. Because of improved clinical outcomes, the majority of European Union member states have or are planning to launch a population-based screening campaign for Breast cancer mammography. In 2021, the targeted therapy segment accounted for roughly 70% of the European Breast cancer therapeutics market. Targeted therapy, which improves the precision of antitumor function while reducing toxicity and damage to normal tissues, is an important component of Breast cancer treatment. Technological advancements and increased research activities in targeted therapy are expected to drive segment growth further. Two Phase III clinical trials are currently underway to compare the efficacy of PARP inhibitors to standard chemotherapy.

The Netherlands Cancer Registry has cancer registry data for the entire country dating back to 1989. (NCR). 5 Long-term trends in cancer epidemiology can be easily studied in the Netherlands due to the high-quality long-running cancer registry. Previously, these data were used to calculate lifetime risks. However, the most frequently cited estimate is from 2003. At the time, the average lifetime risk for invasive tumors was estimated to be 1 in 8 (12.7%),6 while the estimate including in situ tumors was nearly 1% higher.

The risks are determined by the number of diagnoses or deaths in this cohort. All-cause mortality is taken into account when adjusting risks for competing causes of death. The National Cancer Institute developed the DevCan software, which incorporates this method. 10 The program provides risks and 95% confidence intervals (CI) for each 5-year age group. 11,12 The female mid-year population was used to calculate the risk population. This was calculated as the female population's average on January 1 and December 31 of the same year.

In the Netherlands, over 13 000 women were diagnosed with invasive breast cancer in 2010. In 2010, the lifetime risk of developing invasive breast cancer 2023 was estimated to be 13.6% (1 in 7.4 women). The absolute risk difference between 1990 and 2000 is 3.1% (10.5%, or one in every 9.5 women) and 1.1% (12.5%, or one in every 8.0 women), respectively. When DCIS tumors are included, the lifetime risk for 2010 rises by 1.7%. As a result, the combined risk of breast cancer is 15.2%. (1 in 6.6 women). In 1990, the combined risk was 10.8% (1 in 9.3 women) and in 2000, it was 13.5% (1 in 7.4 women).

The life-table method was used to calculate lifetime and age-conditional risks for various years. The calculations were made using the observed incidence and mortality rates from the previous year. The risk of an event occurring after a certain age is conditional on being cancer-free (risk of developing breast cancer) or alive (risk of dying from breast cancer) up until that age The cause of breast cancer in women's health 2023 is becoming more prevalent by the day. Three out of every ten women will be diagnosed with breast cancer, with the remainder suffering from other related diseases. According to the survey, 2200,000 women have been diagnosed with cancer and related diseases. These factors cause 0.5 million deaths annually.

The breast Cancer Therapeutics Market size crossed USD 25.5 billion in 2021 and is expected to grow at an 8% CAGR between 2022 and 2028. The rising incidence of breast cancer is one of the primary factors driving the overall market growth. According to the International Agency for Research on Cancer (WHO), the incidence of Breast cancer in 2020 was 2,261,419, accounting for approximately 11.7% of all cancer cases worldwide.

The COVID-19 pandemic has developed as an unprecedented health hazard, slowing the expansion of the Breast cancer treatments market. The coronavirus outbreak has impacted the worldwide economy, causing economic strain and financial adversity. Priority was given to hospital admissions for COVID-19 impacted patients, delaying other medical procedures. The COVID-19 pandemic reportedly delayed Breast cancer patient screening and treatment in 2021 due to lockdown and infection fears. This is according to a National Centers for Biotechnology Information (NCBI) article. According to the study, the number of Breast cancer patients admitted during the coronavirus outbreak decreased by 15%.

About & Past Conference Report

About Breast Cancer 2023

Our conference's topic includes a wide range of major sessions that provide a deep understanding of breast cancer. Breast Cancer can have an impact on a woman's overall well-being, including immune system problems, cell degeneration, different stages of malignancy, and even the loss of all health and well-being. The conference's main highlights are the pioneers in the field of research and their research projects.

Prominent members of the scientific community who have made significant contributions to the fields of cancer and Breast cancer are participating in the event.

Aim of the conference

To gather in one location for the advancement of science, researchers, scientist, physicians, young academics, and other healthcare professionals.
To talk about the newest developments and trends in Breast Cancer research.
To investigate the possibilities and consider the difficulties in the advancement of medicines for women.
To investigate and discuss novel concepts by creating a forum for speakers and attendees to communicate.
To identify strategies for advancing Breast Cancer, women health, and therapies research in the near future.

We would like to express our gratitude to all of our fantastic keynote speakers, presenters, conference participants, students, associations, media partners, exhibitors, and guests for helping to make Breast Cancer 2021 a wonderful and successful event.

Past Conference report:

Allied Academies held the event of the 10th European Congress on Breast cancer, Women’s health, and therapeutics as Webinar on December 10, 2021, with the topic "Novel trends and advancements in the research of Breast cancer and Women’s health"

This Conference is one of the most interesting and successful events from Allied Academies in 2021 because to the active involvement and generous replies from organizing committee members, scientists, young and sensible researchers, corporate delegations, and academic communities.

The conference was highlighted by the presence of young and brilliant academics, business representatives, and talented student communities from more than 18 nations, who have propelled this event to success. Several talks on the most recent retroviral research served as conference highlights.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Breast cancer

Types of Breast cancer

Surgery for breast cancer
Breast cancer treatment
Breast cancer rehabilitation

Allied Academies has recognized the organizing committee, keynote speakers, and other contributors who made this event a success and appreciates the time and effort put forward by all of the presenters and wishes them luck in their future endeavors.

With the grand success of Breast Cancer 2021, Allied Academies is proud to announce the "11th World Congress on Breast Cancer, Women's Health and Therapeutics” to be held on April27-29,2023 in Amsterdam, Netherlands.

Sessions & Tracks

Session 1: Breast Cancer

Healthcare professionals worldwide are working to develop better strategies for addressing, preventing, diagnosing, and treating Breast Cancer as well as enhancing patient satisfaction with their care. General information regarding Breast Cancer and its risk factors is covered in this Breast Cancer conference. The session includes general information about Breast cancer 2023 and the risk factors associated with it. The discussion here contains the various types of research going on about the intensity of Breast cancer, the risk factors, the impact of it on Women health, and necessary precautions and treatment to be taken before the worse.

Associated Journals: Journal of Cancer immunology, Journal of clinical oncology, Journal of medical cancer research, International journals of radiation oncology, Journal of cancer immunotherapy, European Journal of Breast Cancer, Journal of Clinical Breast Cancer, Journal of mammary Gland Biology, Journal of open Breast Cancer, International Journal of breast cancer target and therapy

Associated Societies: American Breast Cancer Societies, Breast Cancer Research Foundation, Breast Cancer Steering Committee, European society of Breast cancer, International Gynecologic cancer society, society of surgical oncology, American societies of a Breast Surgeon, Advisory Committee on Breast Cancer in young women, British Oncology Society

Session2: Screening of Breast Cancer

Screening tests for Breast Cancer 2023 are to identify cancers before they start to have any negative effects. Early identification refers to the use of a method or test that enables the analysis of breast development earlier than would typically be possible to stop the Breast disease in its early phases, you must learn about screening tests and diagnostic tools for the disease. There are several ways to check for Breast cancer A few tests are essential, while others are more intrusive but provide more information. It is essential to recognize this bosom growth illness early on, regardless One of the most well-known screening methods for Breast Cancer is mammography.

Associated Journals: International journal of Breast screening, Journal of Cancer immunology, Journal of medical cancer research, International journals of radiation oncology, Journal of cancer immunotherapy, Journal of Clinical Breast Cancer, Journal of mammary Gland Biology, Journal of clinical oncology, Journal of open Breast Cancer, International Journal of breast cancer target and therapy

Associated Societies: Breast imaging society, American Breast Cancer Societies, Breast Cancer Steering Committee, European Society of Breast Imaging, International Gynecologic cancer society, society of surgical oncology, American societies of a Breast Surgeon, Advisory Committee on Breast Cancer in young women, British Oncology Society

Session 3: Surgery for Breast Cancer

The common way to remove a Tumor in cancer has always been by surgery. It is the most widely used cancer therapy strategy. Sometimes testing is delayed until after breast-conserving surgery (BCS) or a mastectomy, which removes the entire malignancy. Breast Cancer 2023 surgery methods include segmental mastectomy (Breast-conserving surgery), lumpectomy, partial mastectomy, and double mastectomy (Complete Breast removal) The type of surgery is selected depending on how fast the cancer is growing. Breast-conserving surgery removes cancer while conserving the breast, whereas mastectomy removes the complete breast while preventing cancer from spreading to other organs. It is also a common procedure to operate to remove adjacent lymph nodes.

Associated Journals: Journal of Cancer immunology, Journal of Women Health Care, Journal of Psychiatry, Journal of clinical oncology, Journal of Breast Cancer metastasis, International Journal of Women Health, Journal of medical cancer research, International journals of radiation oncology, Journal of cancer immunotherapy, European Journal of Breast Cancer, Journal of Clinical Breast Cancer, Journal of mammary Gland Biology, Journal of open Breast Cancer, International Journal of breast cancer target and therapy

Associated Societies: American Breast Cancer Societies, Society of Women Health Research, Breast Cancer Research Foundation, Breast Cancer Steering Committee, National Women Network, European society of breast cancer, International Gynecologic cancer society, society of surgical oncology, American societies of Breast Surgeon, British Oncology Society

Session 4: Breast Reconstruction

Breast reconstruction is the procedure of reshaping the Breast, typically in Breast Cancer survivors. The mastectomy fully removes the Women's Breasts from them. The women's lifestyle and mental health may be impacted. The significance of Breast surgery 2023 and the patients' post-treatment lives are discussed in this session.

Associated Journals: Journal of Cancer immunology, Journal of clinical oncology, Journal of medical cancer research, International journals of Radiation oncology, Journal of cancer immunotherapy, European Journal of Breast Cancer, Journal of Clinical Breast Cancer, Journal of mammary Gland Biology, Journal of open Breast Cancer, International Journal of breast cancer target and therapy

Associated Societies: American Breast Cancer Societies, Breast Cancer Research Foundation, Breast Cancer Steering Committee, European society of breast cancer, International Gynecologic cancer society, society of surgical oncology, American societies of a Breast Surgeon, Advisory Committee on Breast Cancer in young women, British Oncology Society

Session 5: Breast disease

The majority of Breast lumps are Benign, or non-cancerous Fibrocystic breasts that are Benign (noncancerous) can appear in both men and women. The term "Benign Breast Disease" refers to this ailment. While neither malignant nor life-threatening, these breast alterations may raise your chance of Breast Cancer in the future.

Associated Journals: International journal of Breast screening, Journal of Cancer immunology, Journal of medical cancer research, International journals of Radiation oncology, Journal of cancer immunotherapy, Journal of Clinical Breast Cancer, Journal of mammary Gland Biology, Journal of clinical oncology, Journal of open Breast Cancer, International Journal of breast cancer target and therapy

Session 6: Breast Cancer Resuscitation

Recovery from cancer therapy may sound like a survival struggle. The reality is that there will be new decisions to be made and perhaps even new chances in life after treatment, particularly for women with Breast Cancer. There are several things that should be applied in daily life to prevent the recurrence of Breast Cancer, such as changing one's eating habits and engaging in regular exercise. the level of estrogen may also decrease, which causes bone density to decline. Exercise can help to increase bone thickness and can be used to stop breast development cycles.

Session 7: Male Breast Cancer

Similar to Breast Cancer 2023 in women, a male chest condition refers to unchecked growth with the potential or spread of some of the cells in this chest tissue. They eventually become so distinctive and direct that they are referred to as cancer cells. Both young men and young women have channels, which are tubular structures, in their chest tissue. Breast cancer can occur in men, despite the fact that women are more likely to have it. Men also have a limited amount of non-functioning Breast tissues in the chest area. According to data from the American Cancer Society, 480 men die from Breast Cancer on average each year. About 2550 males are impacted by the disease.

Session 8: Treatment for Breast Cancer

The two types of treatment for Breast cancer 2023 are local and systemic, and an individual's level of health and well-being relies on their underlying medical condition. Various therapy approaches are used depending on the situation Surgery is the cornerstone of treating bosom disease when the cancer is contained, followed by chemotherapy for cancers that are ER-positive, adjuvant hormonal therapy (with tamoxifen or an aromatase inhibitor). A multidisciplinary team attempts to manage Breast cancer in accordance with national and international regulations, each risk category adhering to different treatment standards. Radiation therapy, chemotherapy, hormone therapy, and invulnerable treatments are all available therapeutic results.

Session 9: Breast Cancer Therapies

One innovative approach to treating Breast Cancer is focused therapies. A few clinical trials performed by Mass General physician researchers are revealing the power of new anticancer therapies in breast growth. Everolimus is a targeted therapy that targets the mTOR protein, which is controlled by a class of drugs known as PI3 kinases (PI3K). mTOR participates in a variety of processes in healthy cells, including protein fusion, cell growth, and many more. Many women who opt against having a mastectomy instead undergo breast-preserving surgery in which only cancer and a small amount of surrounding tissue are removed followed by a six-week course of daily radiation to the entire breast. new patterns to find early signs of bosom illness Finding innovative reconstructive surgery approaches to Molecular Cancer and Breast Cancer Therapeutics, Targeted Therapies, and Breast Cancer Surgery. Determining the best hormonal therapy regimens, anti-angiogenesis, genetic risk, and hereditary testing.

Session 10: Clinical trials in Breast Cancer

Clinical trials for Breast Cancer 2023 have been discovered to be optional; patients engage in the trials as part of their treatment plans, and pre-clinical studies on mice are carried out to identify any negative side effects. Individuals can freely take part in several clinical studies being conducted on Breast Cancer. Pre-clinical studies aid in determining the safety of the proposed course of treatment. All Breast cancer treatments have side effects, which can be dealt with during clinical trials. Clinical trials can also be relevant to Breast cancer research. Genetic-level research is now being done on Breast cancer. According to medical professionals, the breast is negatively affected by defective genes.

Session 11: Chemotherapy for Breast Cancer

Chemotherapy is used to treat cancerous cells in the body by preventing, inhibiting, or killing them. In some circumstances, when the therapy is administered, both cancerous and normal cells are also sometimes eliminated. More than two medication combinations are not used in the treatment of Breast cancer. Chemotherapy is not always necessary, but doctors would prefer it if the patient's tumor was more aggressive Chemotherapy for Breast Cancer 2023 has now been fully administered following this session.

Session 12: Types of Breast Cancer

Breast Cancer can begin in a number of areas of the chest, including the lobules, channels, and even the tissue in the Centre. There, you can learn more about the clear subtypes of breast cancer, such as the benign or sub-nuclear subtypes, as well as the uninvolved, conspicuous, discontinuous, and metastatic chest malignancies. Similarly, you can read about male chest cancer The key phrases are: DCIS, or ductal carcinoma in situ, Invasive Ductal Carcinoma (IDC), Breast tubular carcinoma, IDC Type: Breast Mucinous Carcinoma, IDC Type: Breast Medullary Carcinoma Papillary Breast carcinoma, cribriform breast carcinoma, and other IDC types Invasive lobular carcinoma (ILC)

Session 13: Breast Cancer metastatic

Metastasis is the term used to describe how cancer spreads. When cancer cells move from the primary tumor in the breast and spread to other regions of the body, this is known as metastasis. Even after the initial diagnosis and treatment, Breast Cancer can return to another area of the body months or even years later. This is referred to as a distant or metastatic recurrence. The metastatic illness affects over 30% of women with early-stage Breast Cancer. Men are also diagnosed with metastatic Breast cancer, though it's unclear how frequently because there are so few cases of male Breast cancer. This indicates that the breast cancer has already progressed to another area of the body by the time it is initially discovered

Session 14: Genetics of Breast Cancer:

Cancer-related genes and their heredity are thought to be one of the causes of the death rate of 5–10%. Breast Cancer survivors or mothers are more likely to carry the gene to their children and may be genetically affected for generations if they were diagnosed with the disease before the age of 50. The genetics of breast cancer is linked to two genes, BRCA1 and BRCA2. Breast cancer risk and mortality rates vary from 4 to 5% in people over the age of 80. When it comes to hereditary factors causing Breast Cancer, understanding the genes is crucial.

Session 15: Breast Cancer mastectomy:

A mastectomy is a surgical procedure that removes all or part of your breast tissue. It works as a Breast Cancer 2023 treatment as well as a preventative measure. Surgery is a permanent component of treatment for Breast Cancer. A preventive mastectomy may be suggested by a doctor if you have a high chance of developing Breast cancer in order to help prevent the disease from spreading in the future. There are numerous mastectomies that can remove all or part of your Breast tissue.

Session 16: Mental health

An important link exists between physical and mental health. One's mental health is affected by changes in lifestyle, hormone biology, illnesses, disorders, and psychological variables. Alzheimer's disease, dementia, and other well-known mental illnesses linked to environmental and physiological variables make up the session.

Session 17: Breast Cancer during pregnancy

During pregnancy, your breasts adapt to prepare for breastfeeding. Denser Breast tissue develops. This can make it more difficult to detect cancer-related changes in the breast. A lump is the most prevalent symptom of Breast Cancer. Inform your doctor if a change persists after 2 to 4 weeks. According to research, there is sometimes a delay in diagnosis once women begin to experience breast symptoms during pregnancy. Doctors advise that your therapy should be as comparable to that of a non-pregnant person as possible. And, whenever feasible, therapy should not be postponed.

Associated Societies: Breast imaging society, American Breast Cancer Societies, Breast Cancer Steering Committee, European society of Breast imaging, International Gynecologic cancer society, society of surgical oncology, American societies of a Breast Surgeon, Advisory Committee on Breast Cancer in young women, British Oncology Society.

Session 18: Gynecology in Women's Health

Obstetrics, Breast Cancer, and gynecological health will all be addressed in the session. Gynecological health is related to a woman's reproductive system working well. Menstruation, Birth Control pills, Cervical Cancer, Ovarian Cancer, Endometriosis, HPV, Menopause, and other causes are affecting Gynae health. . Obstetrics discusses pregnancy issues and the postpartum period. Research papers in the Gynecology and Obstetrics category, as well as related sessions, are encouraged. The session is significant and a high point.

Session 19: Researches in Breast Cancer

Breast Cancer and cancer areas are being researched in all aspects such as causes, prevention, and treatment; new treatment approaches are being developed and will be offered in the coming years. Breast Cancer 2023 Research and trials have always been successful since they have worked on women and have resulted in greater treatment innovation. Researchers are still attempting to find out, identify, or remove the tumor in the simplest and quickest way possible. The first stage was educating every woman to recognize whether they had a tumor using certain procedures, which resulted in a significant change in the way Breast cancer was treated

Associated Societies: American Breast Cancer Societies, Breast Cancer Research Foundation, Breast Cancer Steering Committee, European Society of Breast cancer, International Gynecologic cancer society, society of surgical oncology, American societies of a Breast Surgeon, Advisory Committee on Breast Cancer in young women, British Oncology Society

Session 20: Women Oncology

The primary line of defense against the spread of any tumor is growing, which sets off an immune response. In the case of Breast Cancer 2023, a connection exists between the immune system's development and the progression of the tumor. The nature of tumors includes a variety of safe cells that can aid in detecting the movement of breast growth. . In the event that breast cancer develops, treatments used for the disease can alter these resistant cells. Immunoglobulin with specificity for an antigen is released by B lymphocytes, and it may have anticancer characteristics. Patient with Breast cancer has a higher number of B lymphocytes than the average person does in their bone marrow, which can be an important factor in the treatment of Breast cancer conference.